Birth Control Shot Brain Tumor Risk: The Depo-Provera Link

Last Updated: July 16, 2026 | Reviewed by: Legal Lawsuit Editorial Team | Primary Sources: JPML MDL docket records, FDA drug safety communications.

The Birth Control Shot Brain Tumor Link: What the Evidence Shows

If you want fast answers about a possible birth control shot brain tumor connection, here is what current research suggests:

• Higher Risk: Research ties long-term Depo-Provera use to a markedly greater chance of developing a meningioma.
• The Key Figure: A BMJ study from March 2024 reported a 5.6-fold rise in meningioma risk among long-term users.
• What Kind of Tumor: Meningiomas usually grow slowly and are not cancerous, yet they can still cause major health problems.

Depo-Provera, a widely used contraceptive injection, has given millions of women an easy birth control option. Troubling patient accounts and mounting research, however, suggest it may carry serious hidden risks. As of August 2024, neoplasms (tumors) were the side effect reported most often for Depo-Provera in the FDA’s database, including an emerging association with meningioma, a particular type of brain tumor. Below we cover the science, the symptoms to watch for and the legal options for people who have been affected. I’m Mason Arnao. My work in data management and internet marketing has taught me how to explain complicated information clearly, including the developing research on the depo shot brain tumor question, so readers can make informed choices.

Depo-Provera and the Meningioma Question

Choosing birth control usually comes down to finding something reliable that fits your life. The Depo-Provera injection has given many women exactly that convenience. A growing body of research, though, is raising a serious question about a possible link to brain tumors known as meningiomas. To understand it, it helps to look first at how Depo-Provera works and then at what meningiomas are.

How Depo-Provera Works

Depo-Provera is the brand name for medroxyprogesterone acetate (MPA), a synthetic form of the hormone progesterone. It is given as a shot, usually every three months, which is why so many people find it convenient — there is no daily pill to remember. It prevents pregnancy in several ways:

• It stops ovulation, so the ovaries do not release an egg each month.
• It thickens cervical mucus, which makes it much harder for sperm to reach an egg.
• It thins the lining of the uterus, making implantation of a fertilized egg less likely.

Used correctly, Depo-Provera is more than 99% effective at preventing pregnancy. Its convenience is a real advantage, but anyone using or considering it should understand the complete picture, potential risks included. More about the Depo-Provera shot

What Is a Meningioma?

Hearing “brain tumor” is frightening, but meningiomas are often less aggressive than many other brain tumors. A meningioma grows from the meninges, the three protective membranes that wrap the brain and spinal cord like a cushion. Key facts:

• They are common: Meningiomas are the most frequent type of primary brain tumor.
• Most are benign: Roughly 78% to 81% of meningiomas are not cancerous, and they generally grow slowly.
• Location is the problem: Even a benign meningioma can press on the brain, nerves and blood vessels as it grows. That pressure causes symptoms that depend on where the tumor sits and may require significant treatment.

Detailed information on meningiomas

Why Progestins May Matter: The Biological Connection

How could a contraceptive shot be connected to a meningioma? The link involves hormones. Meningiomas are known to be hormone-sensitive, and many carry progesterone receptors on their cells, so they can react to the body’s own progesterone. Depo-Provera’s active ingredient, MPA, is a synthetic progestin. The theory, supported by growing evidence, is that MPA binds to those receptors and may fuel tumor growth or even help tumors form — the core of the depo shot brain tumor concern. The idea is not new. Research from the 1980s and 1990s had already identified hormone sensitivity in meningiomas, and doctors have even used progesterone-blocking drugs to shrink some difficult tumors. Plaintiffs argue this history suggests manufacturers such as Pfizer may have known about the potential link for decades, which is central to current legal arguments about whether U.S. patients were properly warned. More on Depo-Provera’s severe side effects

The Research on Birth Control Shot Brain Tumor Risk

Scientific evidence on the depo shot brain tumor question has built steadily in recent years. No single study can prove Depo-Provera directly causes brain tumors, but the pattern across multiple studies is persuasive and worrying. These are observational studies, which can reveal strong associations without proving cause and effect — much as noticing that umbrella carriers stay drier shows a connection that still needs explaining.

The March 2024 BMJ Study

The study that drew wide attention appeared in the British Medical Journal in March 2024. It was a large analysis drawing on 18,061 women in France who had brain tumor surgery between 2009 and 2018. Women with long-term Depo-Provera use had a 5.6-fold higher risk of meningioma — in plain terms, more than five times as likely to develop this tumor as women who did not use the shot. Notably, the elevated risk appeared with prolonged use of one year or more. The number of Depo-Provera users in the study was small (only 9 participants), yet the size of the risk exceeded that of every other contraceptive examined. The researchers noted it was the first major study to look specifically at Depo-Provera and meningioma, and the strength of the association has made it a pivotal study that doctors and patients cannot overlook. The full BMJ study on progestogens and meningioma risk

Supporting U.S. Data and Other Studies

The French findings were soon echoed. In September 2024, U.S. researchers published an analysis in the journal Cancers showing that women exposed to medroxyprogesterone acetate had 53% higher odds of a meningioma diagnosis overall and 68% higher odds for meningiomas of the brain. Though the numbers differ from the French results, both point the same way: a consistent increase in risk across different populations and health systems. The FDA’s own data adds to the picture. Its Adverse Event Reporting System, which has gathered reports since 1969, showed that by June 2024 neoplasms (tumors) were the most frequently reported side effect for Depo-Provera, with more than 20,000 reports. For perspective, researchers estimate about five in 10,000 women using Depo-Provera may develop a meningioma, compared with about one in 10,000 non-users. The numbers sound small, but each represents a person facing a serious health problem. U.S. based study on Medroxyprogesterone Acetate and Meningioma

Other Serious Depo-Provera Side Effects

A possible birth control shot brain tumor risk is troubling by itself, but it is not the only serious concern. The FDA requires a boxed warning, its strongest, mainly about loss of bone mineral density, and advises against using Depo-Provera for more than two years unless other methods are not suitable. Bone density loss matters because it can lead to osteoporosis and fractures later, a particular worry for young users whose bones are still growing. Many users also report notable weight gain; studies show close to 38% gain substantial weight after two years, which can bring other health problems. Irregular bleeding affects most users — about 57% at one year — often shifting to no periods at all, with 68% having no menstruation after two years. Other concerns include blood clots, which can be deadly if they reach the lungs or brain, a possible higher breast cancer risk particularly for women under 25, and mood effects such as depression and lower libido. Most of these effects reverse after stopping the shot, though the body usually needs a few months to adjust. If you notice worrying symptoms, talk with your doctor about your options.

After a Diagnosis: Your Medical and Legal Options

Learning that your birth control might be connected to a brain tumor can be deeply upsetting. If you used Depo-Provera and now have unusual symptoms, it helps to know the next steps, from getting an accurate diagnosis to understanding your legal rights. Patients deserve full information about the drugs they take, and drug makers have a duty to make products safe and to disclose risks clearly.

Symptoms That May Signal a Meningioma

Meningiomas tend to grow slowly but can produce a wide range of symptoms depending on their size and location. Early signs are often subtle and easy to dismiss, so watch for symptoms that persist or worsen. If you have used Depo-Provera, particularly for a long period, and notice any of the following, see your doctor promptly:

• Headaches: Often persistent, worsening over time and not relieved by ordinary pain relievers.
• Vision changes: Blurriness, double vision (diplopia) or partial or complete vision loss.
• Hearing loss or tinnitus: Reduced hearing or a constant ringing in the ears.
• Memory problems or confusion: Difficulty concentrating or recalling recent events.
• Seizures: Ranging from a brief odd sensation to full-body convulsions.
• Limb weakness or numbness: In an arm, a leg or one side of the body.
• Speech difficulty: Slurred words or trouble finding the right word.
• Loss of smell: Less common, but possible.
• Nausea and vomiting: Particularly when ongoing and unexplained.
• Changes in mood or personality: Unexplained shifts in behavior or emotions.

These symptoms can have many causes, but ruling out a meningioma is important given the growing evidence behind the depo shot brain tumor concern.

How Meningiomas Are Diagnosed and Treated

If a meningioma is suspected, evaluation usually begins with a neurological exam testing reflexes, balance and other nerve function. A firm diagnosis generally requires imaging such as an MRI (Magnetic Resonance Imaging) or a CT (Computed Tomography) scan, and occasionally a biopsy to confirm the tumor type. Treatment depends on the tumor’s size, location and symptoms. Small tumors that cause no problems may be managed with observation — “watchful waiting” with periodic scans to check for growth. When a tumor is reachable and causing symptoms, surgery (a craniotomy) is often preferred, and complete removal cures roughly 70-80% of cases. Radiation therapy may be used when surgery is not possible, when removal is incomplete or when the tumor is aggressive. For inoperable tumors, medications that block progesterone receptors are sometimes considered to help shrink them. Most people with meningiomas have a good outlook: more than 90% of adults aged 20 to 44 survive at least five years after diagnosis. Still, even benign tumors can disrupt daily life, require continued monitoring and leave lasting neurological effects. Brain tumor treatment can also be extremely expensive, and the financial strain adds to the physical and emotional burden. Learn about meningioma diagnosis and treatment

Why People Are Filing Depo-Provera Lawsuits

In light of the research and the serious effects of a meningioma, many women who used Depo-Provera and later developed these tumors are suing Pfizer, the drug’s maker. Their central claim is that Pfizer did not adequately warn patients. Plaintiffs say U.S. labeling long lacked a meningioma warning for American patients and doctors despite earlier studies hinting at the risk. They point to an international gap: in Canada, the label has carried a meningioma warning since 2015, and similar warnings appear in Europe and the UK (U.S. labeling may have changed since these suits began, so check current FDA information). The lawsuits seek to hold the manufacturer accountable for alleged negligence and to compensate people for medical costs, lost income and pain and suffering, sending a message that patient safety must come before profits. Many cases have been consolidated into Multidistrict Litigation (MDL 3140) in the Northern District of Florida to streamline the many similar claims nationwide. If you or a loved one received Depo-Provera (or a generic version) at least twice and were later diagnosed with a meningioma, you may be eligible to file. Legal Lawsuit is a legal-information site that can help: we connect people with experienced attorneys in our network who handle dangerous drug cases across the U.S., including California, Florida, New York, Texas and many other states, through a free, confidential case review. Explore Depo-Provera Lawsuits

Birth Control Shot Brain Tumor FAQs

Hearing that a common medication like Depo-Provera may be tied to a brain tumor naturally raises questions. Here are clear answers to the ones we hear most about the depo shot brain tumor issue.

Does the Depo shot directly cause brain tumors?

Researchers usually describe observational findings as an “association” rather than proof of direct causation, but the evidence connecting long-term Depo-Provera use with meningiomas is substantial. Meningiomas often have progesterone receptors — think of them as docking points — and Depo-Provera’s MPA is a synthetic progestin that may attach to them, potentially speeding the growth of existing tumors or encouraging new ones. The March 2024 BMJ study found long-term users were about 5.6 times more likely to develop meningiomas, a strong signal rather than a minor bump. Lawsuits against Pfizer argue the link was strong enough that patients deserved a clear warning, particularly since other countries required one.

Should I stop Depo-Provera if I’m worried?

That decision belongs to you and your doctor together. Your concern is valid, but it is best not to stop any prescribed medication, Depo-Provera included, without first speaking to a healthcare professional. Your doctor knows your history and why you use Depo-Provera, can help weigh its benefits against possible risks, can review alternative methods that may suit you better and can help you reach a decision that protects your health and peace of mind.

What is the deadline to file a Depo-Provera lawsuit?

Each state sets a statute of limitations, a deadline for filing personal injury claims, including drug injury cases like these. In some states the window can be as short as one year from a meningioma diagnosis, and missing it can end your right to compensation no matter how strong the facts. Talking with an attorney promptly is the best way to protect your options. Attorneys in our network cover all 50 states and the District of Columbia and can explain how the deadline applies to you.

Final Thoughts: Protecting Your Health and Your Rights

Depo-Provera remains a highly effective contraceptive — more than 99% effective — and its three-month schedule explains its popularity. The growing evidence of risk, however, deserves attention. The March 2024 BMJ study found that long-term users face a 5.6-fold higher risk of meningioma, and while these tumors are usually benign, they can cause serious symptoms, require invasive treatment and significantly affect quality of life. Plaintiffs also allege a failure to warn: Canada, the UK and other European countries added meningioma warnings years ago, while U.S. patients say they were not told. Legal Lawsuit believes you deserve the full story about the medications you take. If you have used Depo-Provera and have persistent headaches, vision changes or memory problems, see your doctor promptly for evaluation. If you received at least two injections and were later diagnosed with a meningioma, you may be entitled to compensation for medical bills, lost wages and pain and suffering — and since some states allow as little as one year from diagnosis, timing matters. Our network spans all 50 states and can connect you with experienced attorneys who handle dangerous drug litigation, understand the science behind the birth control shot brain tumor link and know how to pursue claims against large manufacturers like Pfizer. Taking action can also help ensure future patients get the warnings they deserve. Find out if you are eligible for a Depo-Provera Lawsuit today